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Room Temperature Alkynylation of H-Phosphi(na)tes 
and Secondary Phosphine Oxides with 
Ethynylbenziodoxolone (EBX) Reagents 
C. Chun Chen and Jerome Waser a
Highly efficient protocols for the alkynylation of H-
phosphi(na)tes and secondary phosphine oxides with silyl, 
aryl and alkyl ethynyl-benziodoxolone (EBX) reagents are 
reported. Alkynyl phosphorus compounds were obtained in 
69-93% yield without the need for a transition metal catalyst 
at room temperature under open flask conditions. 
Phosphorus-based functional groups are important in biology, 
medicine and synthetic chemistry.1 Synthetic phosphorus 
derivatives display a broad range of bioactivities, including 
drugs like the blood-pressure lowering fosinopril 12a and the 
antiviral cidofovir 22b and the nerve poison sarin 3 (Fig. 1, A). 
Furthermore, ligands such as BINAP 4 based on phosphorus 
play a privileged role in modern organic and organometallic 
chemistry. Phosphonium salts and phosphonic esters are also 
important building blocks to access alkenes via Wittig or 
Horner-Wadsworth-Emmons (HWE) reactions. The 
development of general methods for the synthesis of 
organophosphorus compounds is consequently an important 
goal in organic chemistry.  
In this context, alkynyl phosphorus derivatives constitute an 
important class of building blocks because of the versatile 
reactivity of the triple bond (Fig 1, B).3 Hydration of the alkyne 
leads to -ketophosphonates, which are used in the HWE 
reaction.4 The addition of other nucleophiles has been also 
intensively investigated.3b The use of alkynyl phosphorus in 
[3+2], [4+2] and [2+2+2] cycloadditions5 gives access to 
important phosphorus cyclic compounds, including versatile 
chiral ligands for metal catalysis3b,5f-h or amino acids analogues 
for studies in chemical biology.5a 
To date, four different approaches have been developed for the 
synthesis of alkynyl phosphorus compounds, including: (1) 
reaction of electrophilic alkynes or their precursors with 
nucleophilic phosphorus (III) reagents involving Michaelis-
Arbuzov and Michaelis-Becker reactions,4a,6 (2) reaction of 
nucleophilic alkynes with electrophilic phosphorus,7 (3) -
elimination of heteroatom-substituted vinylphosphonates,8 and 
(4) metal-mediated reaction of H-phosphites with 1,1-dibromo 
alkenes, terminal acetylenes, propiolic acid derivatives, copper 
acetylides or bromo alkynes.9 
 
Fig. 1 Important phosphorus-containing bioactive molecules (A) and alkynyl 
phosphorus derivatives as important building blocks (B). 
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In addition, metal-catalyzed method to access alkynyl 
phosphines have also been reported.10 Despite these different 
alternatives, there are currently no general access to alkynyl 
phosphorus compounds under mild conditions in absence of 
transition metals. Most works focus on only one class of 
phosphorus compounds, especially phosphonates. 
In this context, alkynyl iodonium salts have been long known 
as electrophilic alkynylation reagents,11 but their use for the 
synthesis of alkynyl phosphorus compounds has been limited to 
phosphites6b and phosphonates salts.12 Our group has 
discovered and exploited the properties of cyclic alkynyl 
benziodoxolone reagents, such as TIPS-ethynyl-
benziodoxolone (TIPS-EBX, 6a) for the alkynylation of 
nucleophiles.13 This class of reagents, first synthesized by 
Ochiai and Zhdankin,14 has then later also been exploited by 
others.15 Herein, we would like to report the successful 
alkynylation of H-phosphites, H-phosphinates and secondary 
phosphine oxides at room temperature in open flask and a short 
reaction time (< 5 minutes) using EBX reagents (Scheme 1). 
Scheme 1 Our approach towards phosphorus alkynylation.  
To start our studies, we selected 1,1,3,3-tetramethyl guanidine 
(TMG) for the preparation of alkyne 7a from diethyl 
phosphinate 5a with TIPS-EBX 6a, as it has been the base of 
choice in the case of thiol nucleophiles.13h To our delight, 53% 
isolated yield of 7a was obtained (Table 1, entry 1). Other 
amine bases such as 4-dimethylaminopyridine (4-DMAP), 1,4-
diazabicyclo[2,2,2]octane (DABCO) and triazabicyclodecene 
(TBD) led to lower yields (entries 2-4). In contrast, the use of 
1,8-diazabicycloundec-7-ene (DBU) gave product 7a in 82 % 
isolated yield (entry 5). A fast examination of base and reagent 
loading showed that 1.5 equivalents of DBU and 1.1 
equivalents of TIPS-EBX 6a were optimal (entries 6-8). Other 
solvents gave lower yields when compared to THF (entries 9-
13). Alkynyl phosphite 7a was already formed within 3 min in 
90% isolated yield (entry 14). The formation of 7a was not 
observed in the absence of DBU (entry 15). 
With optimum conditions in hand the scope of H-phosphites 
and H-phosphinates was examined (Scheme 2).16 Dimethyl and 
dibenzyl phosphites 6b and 6c gave the desired product 7b and 
7c in 85% and 89% yield respectively. H-(R)-BINOL phosphite 
derivative 7d was obtained in 86% yield. In addition, alkynes 
7e and 7f were obtained from the corresponding phosphinates 
in 76% and 87% yield respectively. More complex (R)-phenyl 
menthyl and phenyl AZT H-phosphinates were also suitable 
substrates to deliver the products 7g (71%) and 7h (70%) as a 
mixture of diastereoisomers. However, phenylphosphinic acid 
6i could not be converted into alkyne 7i. Substituted ethynyl-
benziodoxolones (R-EBXs), such as Ph-EBX 6b,13f tBu-EBX 
6c,13f and nHex-EBX 6d15g could also be used in this direct 
alkynylation successfully to give products 7j-l. Notably, an 1,5-
C-H insertion product resulting from a carbene intermediate 
was not observed in the alkynylation of 5a with nHex-EBX 6d, 
in contrast to what had been observed when ketoesters were 
used as nucleophiles with alkynyliodonium salts.17 
We then turned our attention to the alkynylation of secondary 
phosphine oxides (SPO) (Scheme 3).16 The alkynylation of this 
class of substrates has been much less studied in the past. 
Indeed, to the best of our knowledge, only the alkynylation of 
diphenyl phosphine oxide 8a has been reported.6d,9e,9f Initially, 
the conditions used in alkynylation of H-phosphites and H-
phosphinates using DBU as a base (Table 1, entry 14) were 
tested for the alkynylation of diphenyl phosphine oxide 8a, but 
only 60% isolated yield of 9a was obtained. TMG, which had 
been the second best base in the case of phosphites, gave better 
results and the alkynylation product 9a was isolated in 91% 
yield. This protocol could also be used in the synthesis of di-(4-
tolyl) phosphinite 9b (89%), di-(4-fluorophenyl) phosphinite 9c 
(93%), di-(n-butyl) phosphinite 9d (86%), and phenyl-t-butyl 
phosphinite 9e (87%). Significantly, cyclic phosphinite 9f can 
be made in 89% yield. However, bulky substituted phosphinite, 
such as 9g and 9h could not be synthesized. We further 
investigated the synthesis of ethynyl phosphinite bearing aryl or 
alkyl groups on the alkyne. Phenylethynyl phosphine 9i and t-
butylethynyl phosphine 9j were obtained in 72% and 87% yield 
respectively. n-Hexyl ethynyl phosphine 9k could also be 
obtained in 85% yield.  
Table 1 Optimization of the alkynylation of phosphite 8a. 
entry equiv. 6a base (equiv.) solvent time (min) yield (%)a 
1 1.2 TMG (2.0) THF 90 55 (53)b 
2 1.2 4-DMAP (2.0) THF 90 0 
3 1.2 DABCO (2.0) THF 90 30 
4 1.2 TBD (2.0) THF 90 0 
5 1.2 DBU (2.0) THF 90 85 (82)b 
6 1.2 DBU (1.5) THF 90 84 
7 1.2 DBU (1.2) THF 90 50 
8 1.1 DBU (1.5) THF 90 89 (88)b 
9 1.1 DBU (1.1) THF 90 45 
10 1.1 DBU (1.5) i-PrOH 90 5 
11 1.1 DBU (1.5) TBME 90 22 
12 1.1 DBU (1.5) MeCN 90 61 
13 1.1 DBU (1.5) CH2Cl2 90 23 
14 1.1 DBU (1.5) THF 3 92 (90)b 
15 1.1 DBU (0) THF 3 or 90 0 
a 0.05 mmol 5a was used. The yield is obtained from 1H-NMR with 1,3,5-
trimethoxybenzene as internal reference. b Isolated yield after purification on 
column chromatography.  
Several plausible mechanisms could be envisaged for the direct 
alkynylation reaction. For the reaction of alkynyliodonium salts 
with carbon nucleophiles, conjugate addition onto the -carbon 
of ethynyl-benziodoxolone, followed by an α-elimination of the 
aryliodide and 1,2-shift rearrangement to deliver the alkyne has 
been most often proposed.17 The fact that no products resulting 
from C-H insertion had been observed in the case of aliphatic 
alkynes could be rationalized by a fast 1,2-shift of the 
phosphorus atom. Nevertheless, an alternative mechanism 
involving nucleophilic attack of phosphi(na)te/phosphine oxide 
onto the iodine atom of benziodoxolone, followed by C-P bond 
formation to give the alkyne product cannot be excluded at this 
stage. A single electron transfer (SET) from 
phosphi(na)te/phosphine oxide to the ethynyl-benziodoxolone, 
could also be proposed as a first step in the reaction. 
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Recombination on the iodine to give an I-P bond followed by 
reductive elimination or direct alkynylation of the phosphorus 
atom would then lead to the observed product. However, when 
TEMPO was added to the reaction mixture under the standard 
reaction conditions (Table 1, entry 14), alkyne 7a was still 
obtained in 85% yield. This result suggests that long-living 
radical intermediates are probably not involved. It is also 
important to notice that SET pathways often require further 
activation of the hypervalent iodine reagent by a Lewis or 
Brønsted acid to facilitate electron transfer, and the developed 
method proceeded under basic conditions.18 
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Scheme 2 Scope of the alkynylation of phosphites and phosphinates. Reaction 
conditions: 0.15–0.29 mmol of H-phosphite or H-phosphinate 5 (1.0 equiv.), 1.5 
equiv. of DBU and 1.2 equiv. of R-EBX 6, 0.1 M in THF at 23 °C. Isolated yield after 
purification on column chromatography is given. b2.5 equiv. of DBU was used in 
the case of 7i. 
Conclusions 
In conclusion, we have described very simple and general 
protocols for the alkynylation of H-phosphites, -phosphinates, 
and secondary phosphine oxides using ethynyl-benziodoxolone 
reagents in good to excellent yield. The developed alkynylation 
method proceeded at room temperature in a few minutes and 
did not require the use of transition metals. It could be applied 
to the synthesis of silyl, alkyl and aryl substituted alkynes and 
was efficient for a broad range of different substituents on 
phosphorus. Further extension of the scope, application of the 
obtained building blocks in synthesis, and more detailed 
investigation of the reaction mechanism are currently ongoing 
in our laboratory and the results will be reported in due course. 
 
Scheme 3 Scope of the H-phosphine oxides. Reaction conditions: 0.15–0.29 
mmol of H-phosphine oxide 8 (1.0 equiv.), 1.5 equiv. of TMG and 1.5 equiv. of R-
EBX 6, 0.1 M in THF at 23 °C. Isolated yield after purification on column 
chromatography is given. 
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1. General Method 
All chemicals were purchased from Acros, Aldrich, Fluka, VWR, Aplichem, Maybrige, TCI 
or Merck and used as such unless stated otherwise. Chromatographic purification was performed 
as flash chromatography using Macherey-Nagel silica 40-63, 60 Å, using the solvents indicated 
as eluent with 0.1-0.5 bar pressure. TLC was performed on Merck silica gel 60 F254 TLC glass 
plates or aluminium plates and visualized with UV light, permanganate stain, CAN stain or 
Anisaldehyde stain.Melting points were measured on a Büchi B-540 melting point apparatus 
using open glass capillaries, the data is uncorrected. 1H-NMR spectra were recorded on a Brucker 
DPX-400 400 MHz spectrometer in chloroform-d, DMSO-d6 or CD3OD, all signals are reported 
in ppm with the internal chloroform signal at 7.26 ppm, the internal DMSO signal at 2.50 ppm or 
the internal methanol signal at 3.30 ppm as standard. The data is being reported as (s =  singlet, d 
=  doublet, t =  triplet, q =  quadruplet, qi =  quintet, m =  multiplet or unresolved, br =  broad 
signal, app =  apparent, coupling constant(s) in Hz, integration, interpretation).13C-NMR spectra 
were recorded with 1H-decoupling on a Bruker DPX-400 100 MHz spectrometer in chloroform-d, 
DMSO-d6 or CD3OD, all signals are reported in ppm with the internal chloroform signal at 77.0 
ppm, the internal DMSO signal at 39.5 ppm or the internal methanol signal at 49.0 ppm as 
standard. 31P-NMR spectra were recorded on a Brucker DPX-400 162 MHz spectrometer in 
chloroform-d. 19F-NMR spectra were recorded on a Brucker DPX-400 376 MHz spectrometer in 
chloroform-d. No internal standard was used for 31P-NMR and 19F-NMR spectra.  Infrared spectra 
were recorded on a JASCO FT-IR B4100 spectrophotometer with an ATR PRO410-S and a ZnSe 
prisma and are reported as cm-1 (w = weak, m = medium, s = strong, br = broad). Gas 
chromatographic and low resolution mass spectrometric measurements were performed on a 
Perkin-Elmer Clarus 600 gas chromatographer and mass spectrometer using a Perkin-Elmer Elite 
fused silica column (length: 30 m, diameter: 0.32 mm) and Helium as carrier gas. High resolution 
mass spectrometric measurements were performed by the mass spectrometry service of ISIC at 
the EPFL on a MICROMASS (ESI) Q-TOF Ultima API.  
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2. Synthesis of Reagents and Starting Materials 
TIPS-EBX (6a), Ph-EBX (6b) and tBu-EBX (6c) were made using our reported protocols.1 
nHex-EBX (6d) was made using a reported procedure.2 
Diethyl phosphite (5a), dimethyl phosphite (5b), dibenzyl phosphite (5c), ethyl 
phenylphosphinate (5e), phenyl phosphoric acid (5i), di-phenylphosphine oxide (8a), 3’-Azido-
3’-deoxythymidine, Di-tert-butylphosphine oxide (8h) are commercially available from Sigma-
Aldrich or TCI.  
Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide (5d), tert-butyl(phenyl)phosphine oxide 
(8e), (2R,5R)-2,5-diphenylphospholane 1-oxide (8f), and dicyclohexylphosphine oxide (8g) were 
generously given by Dr. Pavel Donets and Prof. Nicolai Cramer from the Laboratory of 
Asymmetric Catalysis and Synthesis at EPFL. 
Allyl phenylphosphinate (5f),3 (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl phenylphosphinate 
(5g),4 di-p-tolylphosphine oxide (8b),5 bis(4-fluorophenyl)phosphine oxide (8c),4 
dibutylphosphine oxide (8d),4 t-butyl(phenyl)phosphine oxide (8e), were made using reported 
literature procedures.  
Octynyl-1,2-benziodoxol-3(1H)-one (6d) 
 
Following a slightly modified procedure,6 a solution of 1-octyne (11) (747 mg, 6.78 mmol, 1.00 
eq.) and dry diethyl ether (7.0 mL) was cooled to -78 °C, at which temperature 1.6 M nBuLi in 
hexanes (4.24 mL, 6.78 mmol, 1.00 eq.) was added dropwise. The mixture was stirred at -78 °C 
for 90 minutes and then canullated into a to -78 °C pre-cooled solution consisting of triisopropyl 
borate (1.56 mL, 6.78 mmol, 1.00 eq.) and dry diethyl ether (7.0 mL). The reaction mixture was 
stirred at -78 °C for 2 hours, after which 2.0 M HCl in diethyl ether (3.73 mL, 7.46 mmol, 1.10 
eq.) was added. The cooling bath was removed and the mixture was stirred for an additional 60 
minutes. After filtration and solvent removal, Kugelrohr distillation (75 °C at 0.6 mbar) furnished 
pure diisopropyloct-1-ynylboronate (12, 940 mg, 3.95 mmol, 58% yield) as a colorless liquid. 
1H-NMR (400 MHz, CDCl3) δ 4.55 (hept, 2H, J = 6.2 Hz, CHO), 2.27 (t, 2H, J = 7.0 Hz, 
                                                          
1 (a) Brand, J. P.; Waser, J. Synthesis 2012, 44, 1155. (b) Brand, J. P.; Chevalley, C.; Scopelliti, R.; Waser, J. Chem. 
Eur. J. 2012, 18, 5655. 
2 Meouma, J. B.; Olofsson, B. Chen. Eur J. 2012, 18, 3690. 
3 Fourgeaud, P.; Midrier, C.; Vors, J.-P.; Volle, J.-N.; Pirat, J.-L.; Virieux, D. Tetrahedron 2010, 66, 758. 
4 Xu, Q.; Zhao, C.-Q.; Han, L.-B. J. Am. Chem. Soc. 2008, 130, 12648. 
5 Busacca, C. A.; Lorenz, J. C.; Grinberg, N.; Haddad, N.; Hrapchak, M.; Latil, B.; Lee, H.; Sabila, P.; Saha, A.; 
Sarvestani, M.; Chen, S.; Varsolona, R.; Wei, X. ; Senanayake, C. H. Org. Lett. 2005, 7, 4277.  
6 Brown, H. C.; Bhat, N. G.; Srebnik, M. Tetrahedron Lett. 1988, 29, 2631. 
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propargylic CH2), 1.60-1.48 (m, 2H, CH2), 1.45-1.24 (m, 6H, CH2), 1.19 (d, 12H, J = 6.2 Hz, 
iPr 
CH3), 0.89 (t, 3H, J = 6.9 Hz, hexyl CH3). The values of the 
1H NMR spectrum are in accordance 
with reported literature data.6     
Following a slightly modified procedure,2 2-iodobenzoic acid (10) (692 mg, 2.79 mmol, 1.00 
eq.), para-toluenesulfonic acid monohydrate (TsOH•H2O, 531 mg, 2.79 mmol, 1.00 eq.) and 
meta-chloroperoxybenzoic acid (mCPBA-70%, 756 mg, 3.07 mmol, 1.10 eq.) were dissolved in 
dichloromethane (4.5 mL) and 2,2,2-trifluoroethanol (4.5 mL). The mixture was stirred at room 
temperature under nitrogen for 1 hour, after which diisopropyloct-1-ynylboronate (12, 930 mg, 
3.90 mmol, 1.40 eq.) was added in one portion. The reaction mixture was stirred for 2 hours at 
room temperature, filtered and concentrated in vacuo. The resulting oil was dissolved in 
dichloromethane (30 mL) and under vigorous stirring, saturated aq. NaHCO3 (30 mL) was added. 
The mixture was stirred for 15 minutes, the two layers were separated and the aqueous layer was 
extracted with additional portions of dichloromethane (3 x 10 mL). The combined organic layers 
were dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified by 
flash column chromatography (ethyl acetate) to afford 6d (940 mg, 2.64 mmol, 95%) as a white 
solid. Rf (EtOAc) = 0.25. 1H-NMR (400 MHz, CDCl3) δ 8.42-8.35 (m, 1H, ArH), 8.20-8.13 (m, 
1H, ArH), 7.78-7.69 (m, 2H, ArH), 2.59 (t, 2H, J = 7.1 Hz, CCCH2), 1.70-1.58 (m, 2H, CH2), 
1.51-1.39 (m, 2H, CH2), 1.38-1.26 (m, 4H, CH2), 0.94-0.86 (m, 3H, CH2CH3). 13C-NMR (101 
MHz, CDCl3) δ 166.7, 134.7, 132.5, 131.7, 131.6, 126.3, 115.7, 109.9, 39.4, 31.3, 28.7, 28.3, 
22.6, 20.6, 14.1. The characterization data is in accordance with reported literature values.7 
 
Allyl phenylphosphinate (5f) 
 
Product 5f was made by using the known procedure reported by Virieux and co-workers.3 Pyridine 
(3.0 mL, 36 mmol) was added to a stirring solution of phenylphosphinic acid (5.17 g, 36.4 mmol) 
and allyl chloroformate (4.0 mL, 36 mmol) in CH2Cl2 (70 mL) at room temperature. This 
reaction was stirred for 30 min. Once gas evolution was stopped, the resulting mixture was heated 
at reflux for 15 min, and cooled down to room temperature. 0.1 N aqueous solution (50 mL) was 
added to the resulting mixture, and stirred for 30 min. The organic layer was separated, washed 
with water (2 * 50 mL), and dried over Na2SO4. The resulting solution was filtered and organic 
solvent was removed under reduced pressure. The remaining oil was distilled under vacuum to 
give pure 5f (3.93 g, 21.6 mmol, 59%). 1H-NMR (400 MHz, CDCl3) δ 7.90 – 7.85 (m, 2H, Ph 
H), 7.65 – 7.61 (m, 1H, Ph H), 7.65 (d, J = 400 Hz, 1H, PH), 7.56 – 7.52 (m, 2H, Ph H), 5.97 
(ddtd, J = 17.0, 10.3, 5.6, 0.8 Hz, 1H, alkene CH), 5.46 – 5.35 (m, 1H), 5.28 (dt, J = 10.5, 1.1 Hz, 
                                                          
7 Huang, H.; Zhang, G.; Gong, L.; Zhang, S.; Chen, Y. J. Am. Chem. Soc., 2014, 136, 2280. 
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1H, alkene CH2), 4.60 (dddt, J = 16.1, 9.5, 5.5, 1.6 Hz, 2H, CH2O). The characterization data is 
in accordance with reported literature values.3 
 
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl phenylphosphinate (5g)4 
 
Product 5g was made by using the known procedure reported by Han and co-workers.4 PhPCl2 (13) 
(4.34 mL, 32.0 mmol) in dry Et2O (10 mL) was added to a mixture of pyridine (2.59 mL, 32.0 mmol) and 
R-menthol (5.0 g, 32 mmol) in dry Et2O (30 mL) at 0 ⁰C, and the resulting solution was stirred at 
room temperature overnight. H2O (3 mL) was added, and the reaction mixture was washed with 
H2O and extracted with hexane (60 mL * 3 times). The organic layer was separated, dried over 
MgSO4, and filtrated. The organic solvent was removed under reduced pressure to give a crude 
oil. The oil was distilled under vacuum to give the pure adduct 5g (5.2 g, 19 mmol, 58%). The 
diastereomeric ratio is 1:1.6 calculated based on integration of peaks in 31P-NMR. 1H-NMR (400 
MHz, CDCl3) δ 8.37 (d, J = 485 Hz, 1H, PH), 7.80 (ddt, J = 14.1, 8.2, 1.3 Hz, 2H, Ph H), 7.67 – 
7.57 (m, 1H, Ph H), 7.56 – 7.47 (m, 2H, Ph H), 4.29 (td, J = 10.5, 4.5 Hz, 1H, CHO), 2.38 – 2.04 
(m, 2H, CH or CH2), 1.79 – 1.62 (m, 2H, CH or CH2), 1.47 (ddt, J = 13.1, 6.7, 3.4 Hz, 2H, CH or 
CH2), 1.36 – 1.19 (m, 1H, CH or CH2), 1.04 – 0.78 (m, 11H, CH, CH2 and CH3). 31P-NMR (162 
MHz, CDCl3) δ 21.3, 22.7. The characterization data is in accordance with reported literature 
values.4 
 
((2S,3S,5R)-3-Azido-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-
2-yl)methyl phenylphosphinate (5h) 
 
Product 5h was made by using the known procedure reported by Han and co-workers.4 PhPCl2 (13) 
(0.16 mL, 1.2 mmol) in dry Et2O (2 mL) was added to a mixture of pyridine (0.19 mL, 2.3 mmol) and 
AZT (0.30 g, 1.1 mmol) in dry Et2O (6 mL) at 0 ⁰C, and the resulting solution was stirred at room 
temperature overnight. H2O (2 mL) was added, and the reaction mixture was washed with H2O (5 
mL) and extracted with EtOAc (5 mL * 5 times). The organic layer was separated, dried over 
MgSO4, and filtrated. The organic solvent was removed under reduced pressure to give a crude 
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gel. The crude gel was purified by column chromatography (MeOH/CH2Cl2 1/10) to give the 
product 5h as a pale brown gel (0.20 g, 0.52 mmol, 47%, ca. 95% purity). Rf 0.25 
(MeOH/CH2Cl2 1/8, KMnO4). The diastereomeric ratio is 1:1 which was calculated based on 
integration of peaks in 1H-NMR at 7.14 and 6.85 ppm. 1H-NMR (400 MHz, CDCl3) δ 7.78 (d, J 
= 490 Hz, 1H, PH), 7.67 (dd, J = 14.1, 8.3, 2.5, 1.4 Hz, 2H, Ph H), 7.52 – 7.45 (m, 1H, Ph H), 
7.43 – 7.34 (m, 2H, Ph H), 7.14 (s, 0.5H, CH thymine, 1. diastereoisomer), 6.85 (s, 0.5H, CH 
thymine, 2. diastereoisomer), 6.08 (dt, J = 11.4, 6.5 Hz, 1H, CHON), 4.40 – 4.16 (m, 3H, CH2O 
and CHO), 3.94 (dq, J = 8.1, 3.7 Hz, 1H, CHN3), 2.35 – 2.17 (m, 2H, CH2), 1.70 (s, 1.5H, Me 
thymine, 1. diastereoisomer), 1.58 (s, 1.5H, Me thymine, 2. diastereoisomer). 13C-NMR (101 
MHz, CDCl3) δ 163.9, 150.3, 142.6, 136.8, 132.7 (d, J = 3.0 Hz), 132.1, 130.7 (d, J = 12.1 Hz), 
128.6 (d, J = 13.9 Hz), 126.7, 111.2, 85.5 (d, J = 186.0 Hz), 60.9 (d, J = 183.5 Hz), 37.3, 12.5. 
31P-NMR (162 MHz, CDCl3) δ 22.2.8 IR 3662(m), 2989(s), 2107(w), 1693(m), 1408(m), 
1255(m), 1067(s), 894 (m). 
 
Di-p-tolylphosphine oxide (8b)5 
 
Product 8b was made by using the known procedure reported by Busacca and co-workers.5 A 
solution of diethylphosphite (5a) (1.5 mL, 12 mmol) in 10 mL THF was added dropwise to 1.0 M 
TolMgBr in THF (38.4 mL) at 0 ⁰C. The resulting solution was stirred at 0 ⁰C degree for 15 min 
and at room temperature for 30 min, and cooled down to 0 ⁰C again before 0.1 N HCl aqueous 
solution (10 mL) was added. TBME (30 mL) was added to the resulting mixture and stirred for 5 
min. The upper organic layer was decanted from the gel. CH2Cl2 (35 mL) was subsequently 
added to the gel and stirred for 5 min. The resulting mixture was then filtered through a celite 
pad, washing the pad with CH2Cl2 (35 mL). The organic layer was separated. All combined 
organic solutions were dried over MgSO4 and the solvent was removed under reduced pressure to 
give a crude solid. The solid was recrystallized from boiling EtOAc (15 mL) to give the 
corresponding 8b as a colorless solid (2.3 g, 9.8 mmol, 84%). 1H-NMR (400 MHz, CDCl3) δ 
8.06 (d, J = 500 Hz, 1H, PH), 7.60 (ddd, J = 13.7, 8.1, 1.6 Hz, 4H, Tol CH), 7.35 – 7.29 (m, 4H, 
Tol CH), 2.43 (s, 6H, Me). The characterization data is not in accordance with reported literature 
values, as the tolyl Me peak was missing in the reported data.5 The other peaks are 
corresponding. 
 
                                                          
8 The phosphorous signal of both diastereoisomers was overlapping. 
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Bis(4-fluorophenyl)phosphine oxide (8c)4 
 
Product 8c was made by using the known procedure reported by Busacca and co-workers.5 
Diethylphosphite (5a) (1.0 mL, 7.7 mmol) in 8 mL THF was added dropwise to a solution of p-
FC6H4MgBr in 10 mL THF (prepared from 0.64 g Mg (26 mmol) with 2.81 mL p-FC6H4Br (25.6 
mmol)) at 0 ⁰C. The resulting solution was stirred at 0 ⁰C degree for 15 min and at room 
temperature for 30 min, and cooled down to 0 ⁰C again before 0.1 N HCl aqueous solution (10 
mL) was added. TBME (25 mL) was added to the resulting mixture and stirred for 5 min. The 
upper organic layer was decanted from the gel. CH2Cl2 (25 mL) was subsequently added to the 
gel and stirred for 5 min. The resulting mixture was then filtered through a celite pad, washing 
the pad with CH2Cl2 (25 mL). The organic layer was separated. All combined organic solutions 
were dried over MgSO4 and the solvent was removed under reduced pressure to give a crude oil. 
The crude oil was purified by column chromatography (pentane/EtOAc 2.5/1) to give the product 
8c as a colorless oil (1.4 g, 5.7 mmol, 73%). 1H-NMR (400 MHz, CDCl3) δ 8.11 (d, J = 485 Hz, 
1H, PH), 7.72 (ddd, J = 13.1, 8.6, 5.5 Hz, 4H, Ar CH), 7.28 – 7.19 (m, 4H, Ar CH). The 
characterization data is in accordance with reported literature values.5 
Dibutylphosphine oxide (8d)5 
 
Product 8d was made by using the known procedure reported by Busacca and co-workers.5A 
solution of diethylphosphite (5a) (3.0 mL, 23 mmol) in 10 mL THF was added dropwise to 2.5 M 
nBuLi in THF (30.7 mL, 77.0 mmol) at 0 ⁰C. The resulting solution was stirred at 0 ⁰C degree for 
15 min and at room temperature for 30 min, and cooled down to 0 ⁰C again before 0.1 N HCl 
aqueous solution (20 mL) was added. TBME (40 mL) was added to the resulting mixture and 
stirred for 5 min. The upper organic layer was decanted from the gel. CH2Cl2 (50 mL) was 
subsequently added to the gel and stirred for 5 min. The resulting mixture was then filtered 
through a celite pad, washing the pad with CH2Cl2 (50 mL). The organic layer was separated. All 
combined organic solutions were dried over MgSO4 and the solvent was removed under reduced 
pressure to give a crude gel. The gel was recrystallized from boiling hexane (15 mL) to give 8d 
as a colorless solid (3.3 g, 20 mmol, 87%). 1H-NMR (400 MHz, CDCl3) δ 7.59 – 6.19 (dm, J = 
446 Hz, 1H, PH), 1.92 – 1.51 (m, 8H, CH2), 1.51 – 1.37 (m, 4H, CH2), 0.93 (t, J = 7.3 Hz, 6H, 
CH3). The characterization data is in accordance with reported literature values.
5  
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3. Alkynylation Reaction 
Optimization procedure:  
To a stirring solution of TIPS-EBX (6a) (1.1 – 1.2 equiv) and base (1.1 – 2.0 equiv) in solvent 
(0.1 M) was added diethyl phosphite 5a (7.3 mg, 0.050 mmol, 1.0 equiv). The resulting solution 
was then stirred at r.t for 3 or 90 min. Subsequently 1M HCl (3 mL) and EtOAc (3 mL) were 
added to quench the resulting mixture. The organic layer was separated, and the aqueous layer 
was extracted with EtOAc (3 mL * 3). All combined organic layers were washed with sat. 
NaHCO3 (5 mL * 2), dried over MgSO4, and removed under reduced pressure to give a crude 
adduct. Yield (%) based on 1H-NMR with 1,3,5-trimethoxybenzene as internal reference. Pure 
product 7a was further obtained by column chromatographic purification. Rf 0.55 
(pentane/EtOAc 1/1, KMnO4); pentane/EtOAc 1/1 was used as the eluting solvents for 
purification. 
General procedure A: 
 
 
To a stirring solution of TIPS-, Ph-, tBu- or nHex-EBX 6 (1.1 equiv) and DBU (1.5 equiv) in 
THF (0.1 M) was added phosphite or phosphinate 5 (0.15–0.29 mmol, 1.0 equiv). The resulting 
solution was then stirred at r.t for 3 min. Subsequently 1M HCl (3 mL) and EtOAc (3 mL) were 
added to quench the resulting mixture. The organic layer was separated, and the aqueous layer 
was extracted with EtOAc (3 mL * 3). All combined organic layers were washed with sat. 
NaHCO3 (5 mL * 2), dried over MgSO4, and removed under reduced pressure to give a crude 
adduct. The pure corresponding product was obtained by column chromatographic purification. 
General procedure B: 
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To a stirring solution of TIPS-, Ph-, tBu- or nHex-EBX 6 (1.5 equiv) and TMG (1.5 equiv) in 
THF (0.1 M) was added phosphine oxide 8 (0.15–0.29 mmol, 1.0 equiv). The resulting solution 
was then stirred at r.t for 3 min. Subsequently 1M HCl (3 mL) and EtOAc (3 mL) were added to 
quench the resulting mixture. The organic layer was separated, and the aqueous layer was 
extracted with EtOAc (3 mL * 3). All combined organic layers were washed with sat. NaHCO3 (5 
mL * 2), dried over MgSO4, and removed under reduced pressure to give a crude adduct. The 
pure corresponding product was obtained by column chromatographic purification. 
 
Diethyl ((triisopropylsilyl)ethynyl)phosphonate (7a) 
 
H-phosphite 5a (45 mg, 0.32 mmol) and TIPS-EBX (6a) were used in general procedure A. 10a 
was obtained as a colorless gel (91 mg, 0.28 mmol, 90% yield). Rf 0.55 (pentane/EtOAc 1/1, 
KMnO4); pentane/EtOAc 1/1 was used as the eluting solvents for purification. 1H-NMR (400 
MHz, CDCl3) δ 4.15 (dd, J = 8.9, 7.1, 0.7 Hz, 4H, CH2O), 1.36 (td, J = 7.1, 0.7 Hz, 6H, ethyl 
CH3), 1.15 – 1.04 (m, 21H, TIPS). 13C-NMR (101 MHz, CDCl3) δ 106.5 (d, J = 37.6 Hz), 96.4 
(d, J = 269.7 Hz), 63.1 (d, J = 5.5 Hz), 17.7, 16.06 (d, J = 6.9 Hz), 10.8. 31P-NMR (162 MHz, 
CDCl3) δ -8.5. IR 3669(s), 2998(s), 2361(s), 2180(w), 1408(s), 1252(s), 1079(s), 883(s), 819(m). 
HRMS (ESI) calcd for C15H32O3PSi
+ [M+H]+ 319.1853, found 319.1857. 
 
Dimethyl ((triisopropylsilyl)ethynyl)phosphonate (7b) 
 
H-phosphite 5b (35 mg, 0.32 mmol) and TIPS-EBX (6a) were used in general procedure A. 7b 
was obtained as a colorless gel (79 mg, 0.27 mmol, 85% yield). Rf 0.55 (pentane/EtOAc 1/1, 
KMnO4); pentane/EtOAc 1/1 was used as the eluting solvents for purification. 1H-NMR (400 
MHz, CDCl3) δ 4.12 (d, J = 8.9 Hz, 6H, Me), 1.45 – 1.17 (m, 21H, TIPS). 13C-NMR (101 MHz, 
CDCl3) δ 107.9 (d, J = 37.9 Hz), 94.6 (d, J = 273.0 Hz), 53.4 (d, J = 5.6 Hz), 18.4, 10.8. 31P-
NMR (162 MHz, CDCl3) δ -5.2. IR 3674(s), 2989(s), 2361(s), 2180(w), 1251(s), 1081(s), 
893(m), 822(m). HRMS (ESI) calcd for C13H28O3PSi
+ [M+H]+ 291.1540, found 291.1541. 
 
Dibenzyl ((triisopropylsilyl)ethynyl)phosphonate (7c) 
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H-phosphite 5c (88 mg, 0.32 mmol) and TIPS-EBX (6a) were used in general procedure A. 7c 
was obtained as a colorless gel (126 mg, 0.283 mmol, 89% yield). Rf 0.7 (pentane/EtOAc 1/1, 
KMnO4); pentane/EtOAc 2/1 was used as the eluting solvents for purification. 1H-NMR (400 
MHz, CDCl3) δ 7.49 – 7.30 (m, 10H, CH Ph), 5.14 (d, J = 8.5 Hz, 4H, Bn CH2), 1.25 – 0.97 (m, 
21H, TIPS). 13C-NMR (101 MHz, CDCl3) δ 135.5 (d, J = 7.5 Hz), 128.5, 128.5, 127.8, 107.8 (d, 
J = 38.3 Hz), 95.8 (d, J = 274.7 Hz), 68.5 (d, J = 5.2 Hz), 18.5, 10.8. 31P-NMR (162 MHz, 
CDCl3) δ -8.0. IR 3674(s), 2972(s), 2902(s), 2361(s), 2180(w), 1933(w), 1454(m), 1394(s), 
1251(s), 1056(s), 881(s), 785(w). HRMS (ESI) calcd for C25H36O3PSi
+ [M+H]+ 443.2166, found 
443.2172. 
 
4-((Triisopropylsilyl)ethynyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide (7d) 
 
H-phosphite 5d (60 mg, 0.18 mmol) and TIPS-EBX (6a) were used in general procedure A. 7d 
was obtained as a colorless gel (80 mg, 0.16 mmol, 86% yield). Rf 0.8 (pentane/EtOAc 1/1, 
KMnO4); pentane/EtOAc 3/1 was used as the eluting solvents for purification. [α]D23.0 -63.7(c = 
0.44, CHCl3). 1H-NMR (400 MHz, CDCl3) δ 8.09 – 7.92 (m, 4H, Ar H), 7.63 (dd, J = 8.8, 1.1 
Hz, 1H, Ar H), 7.58 – 7.47 (m, 3H, Ar H), 7.46 – 7.29 (m, 4H, Ar H), 1.15 – 1.00 (m, 21H, 
TIPS). 13C-NMR (101 MHz, CDCl3) δ 146.7 (d, J = 10.9 Hz), 145.4 (d, J = 9.1 Hz), 132.3 (d, J = 
9.3 Hz), 131.9 (d, J = 4.9 Hz), 131.4, 130.9, 128.5 (d, J = 11.4 Hz), 127.2 (d, J = 28.1 Hz), 126.7 
(d, J = 3.7 Hz), 125.9, 121.8 (dd, J = 13.6, 2.6 Hz), 120.9 (dd, J = 27.4, 3.0 Hz), 111.3 (d, J = 
39.5 Hz), 93.2 (d, J = 294.2 Hz), 18.4, 10.8.9 31P-NMR (162 MHz, CDCl3) δ -1.91. IR 3669(s), 
2991(s), 2361(s), 2180(w), 1934(w), 1407(s), 1251(s), 1076(s), 893(s). HRMS (ESI) calcd for 
C31H34O3PSi
+ [M+H]+ 513.2009, found 513.2003. 
 
Ethyl phenyl((triisopropylsilyl)ethynyl)phosphinate (7e) 
 
H-phosphinate 5e (54 mg, 0.32 mmol) and TIPS-EBX (6a) were used in general procedure A. 7e 
was obtained as a colorless gel (85 mg, 0.24 mmol, 76% yield). Rf 0.5 (pentane/EtOAc 1/1, 
KMnO4); pentane/EtOAc 2/1 was used as the eluting solvents for purification. 1H-NMR (400 
MHz, CDCl3) δ 7.90 (ddd, J = 14.4, 7.5, 1.4 Hz, 2H, Ar H), 7.56 (dd, J = 7.5, 1.4 Hz, 1H, Ar H), 
7.48 (d, J = 3.8 Hz, 2H, Ar H), 4.36 – 4.17 (m, 2H, ethyl CH2), 1.40 (t, J = 7.0 Hz, 3H, ethyl 
CH3), 1.21 – 0.98 (m, 21H, TIPS). 13C-NMR (101 MHz, CDCl3) δ 132.6 (d, J = 3.1 Hz), 131.2 
(d, J = 170.3 Hz), 130.9 (d, J = 11.3 Hz), 128.4 (d, J = 14.9 Hz), 109.2 (d, J = 26.4 Hz), 99.8 (d, J 
= 192.3 Hz), 62.3 (d, J = 6.6 Hz), 18.4, 16.3 (d, J = 6.9 Hz), 10.9. 31P-NMR (162 MHz, CDCl3) δ 
8.1. IR 3674(s), 3392(w), 3228(w), 2972(s), 2361(s), 2180(w), 1933(w), 1452(m), 1394(s), 
                                                          
9 Not all aromatic signals were resolved.  
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1250(s), 1053(s), 881(s), 801(m). HRMS (ESI) calcd for C19H32O2PSi
+ [M+H]+ 351.1904, found 
351.1909. 
 
Allyl phenyl((triisopropylsilyl)ethynyl)phosphinate (7f) 
 
H-phosphinate 5f (58 mg, 0.32 mmol) and TIPS-EBX (6a) were used in general procedure A. 7f 
was obtained as a colorless gel (100 mg, 0.285 mmol, 87% yield). Rf 0.6 (pentane/EtOAc 1/1, 
KMnO4); pentane/EtOAc 1/1 was used as the eluting solvents for purification. 1H-NMR (400 
MHz, CDCl3) δ 7.97 – 7.81 (m, 2H, Ph CH), 7.59 – 7.51 (m, 1H, Ph CH), 7.50 – 7.43 (m, 2H, Ph 
CH), 5.98 (ddt, J = 17.1, 10.7, 5.5 Hz, 1H, alkene CH), 5.37 (dq, J = 17.1, 1.5 Hz, 1H, alkene 
CH2), 5.23 (dq, J = 10.3, 1.3 Hz, 1H, alkene CH2), 4.66 (ddt, J = 7.0, 4.1, 1.6 Hz, 2H, CH2O), 
1.19 – 0.98 (m, 21H, TIPS). 13C-NMR (101 MHz, CDCl3) δ 132.8 (d, J = 3.0 Hz), 132.6 (d, J = 
7.4 Hz), 130.9 (d, J = 11.4 Hz), 130.9 (d, J = 170.5 Hz), 128.5 (d, J = 15.0 Hz), 118.2, 109.7 (d, J 
= 26.8 Hz), 99.5 (d, J = 193.5 Hz), 66.4 (d, J = 6.2 Hz), 18.4, 10.9. 31P-NMR (162 MHz, CDCl3) 
δ 8.6. IR 3676(s), 2964(s), 2361 (s), 2125(w), 1923(w), 1452(m), 1407(s), 1251(s), 1057(s), 
881(s), 792(m). HRMS (ESI) calcd for C20H32O2PSi
+ [M+H]+ 362.1830, found 363.1904. 
 
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl phenyl((triisopropylsilyl)ethynyl)phosphinate 
(7g) 
 
H-phosphinate 5g (108 mg, 0.372 mmol) and TIPS-EBX (6a) were used in general procedure A. 
7g was obtained as a colorless gel (119 mg, 0.264 mmol, 71% yield). The diastereomeric ratio is 
1:1, which was calculated based on integration of peaks in 31P-NMR. Rf 0.8 (pentane/EtOAc 1/1, 
KMnO4); pentane/EtOAc 2.5/1 was used as the eluting solvents for purification. 1H-NMR (400 
MHz, CDCl3) δ 7.90 (dddd, J = 14.3, 8.4, 4.1, 1.4 Hz, 2H, Ph CH), 7.59 – 7.52 (m, 1H, Ph CH), 
7.48 (tdd, J = 6.8, 3.9, 1.4 Hz, 2H, Ph CH), 4.46 (tdd, J = 10.8, 7.8, 4.4 Hz, 1H, CHO), 2.62 – 
2.34 (m, 1H, aliphatic H), 1.79 – 1.62 (m, 2H, aliphatic H), 1.36 – 1.21 (m, 2H, aliphatic H), 1.20 
– 1.04 (m, 25H, aliphatic H and TIPS), 0.98 – 0.86 (m, 9H, aliphatic H and TIPS). 13C-NMR 
(101 MHz, CDCl3) δ 132.9 (d, J = 170.5 Hz), 132.4, 132.4, 132.1, 130.9, 130.8, 130.6, 128.3 (d, 
J = 15.0 Hz), 109.3 (d, J = 26.0 Hz), 108.6 (d, J = 26.2 Hz), 101.3 (d, J = 190.7 Hz), 100.5 (d, J = 
190.7 Hz), 79.6 (d, J = 8.1 Hz), 78.5 (d, J = 7.9 Hz), 48.6, 48.6, 48.5, 43.7, 42.6, 34.1 (d, J = 2.8 
Hz), 31.7, 31.6, 25.8, 25.5, 23.1, 23.0, 21.9, 21.9, 21.0 (d, J = 2.0 Hz), 18.5, 18.4, 17.7, 16.2, 
15.6, 12.3, 11.0 (d, J = 1.9 Hz).10 31P-NMR (162 MHz, CDCl3) δ 7.1, 5.1. IR 3674(s), 2988(s), 
                                                          
10 Not all aliphatic signals were resolved. 
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2361(s), 2180(w), 1453(m), 1407(s), 1250(s), 1079(s), 882(s), 787(m). HRMS (ESI) calcd for 
C27H45O2PSi
+M+H) 461.2926, found 461.2998. 
 
3’-Azido-3’-deoxythymidinyl phenyl((triisopropylsilyl)ethynyl)phosphinate (7h) 
 
 
H-phosphinate 5h (172 mg, 0.443 mmol) and TIPS-EBX (6a) were used in general procedure A. 
7h was obtained as a colorless gel (176 mg, 0.313 mmol, 70% yield). The diastereomeric ratio is 
1:1.3, which was calculated based on average integration of peaks in 1H-NMR at 7.42 and 7.23 
ppm, and 31P-NMR. Rf 0.45 (pentane/EtOAc 1/1, KMnO4); pentane/EtOAc 2.5/1 was used as the 
eluting solvents for purification. 1H-NMR (400 MHz, CDCl3) δ 9.14 (s, 1H, NH), 7.90 (ddd, J = 
14.5, 7.9, 6.4 Hz, 2H, Ph CH), 7.64 (td, J = 7.4, 1.6 Hz, 1H, Ph CH), 7.58 – 7.49 (m, 2H, Ph CH), 
7.42 (s, 0.4H, CH thymine, 1. diastereoisomer), 7.23 (s, 0.6H) , CH thymine, 2. diastereoisomer, 
6.36 – 6.11 (m, 1H, CHON), 4.56 – 4.27 (m, 3H, CHO and CH2O), 4.12 (dd, J = 8.7, 3.4 Hz, 1H, 
CHN3), 2.44 (dtd, J = 13.6, 6.4, 3.7 Hz, 1H, CH2), 2.21 (ddt, J = 23.2, 14.1, 7.3 Hz, 1H, CH2), 
1.75 (s, 1.3H, Me thymine, 1. diastereoisomer), 1.64 (s, 1.7H, Me thymine, 2. diastereoisomer), 
1.23 – 1.00 (m, 21H, TIPS). 13C-NMR (CDCl3, 100MHz) δ 163.7, 163.6, 150.3, 150.2, 135.0, 
134.8, 133.5, 133.5, 130.8 (d, J = 11.9 Hz), 130.8 (d, J = 11.7 Hz), 130.5, 129.2, 128.8 (d, J = 
15.2 Hz), 111.8 (d, J = 26.7 Hz), 111.5, 111.4, 99.3 (d, J = 196.0 Hz), 98.1 (d, J = 196.0 Hz), 
84.6 , 84.6, 82.5 (d, J = 7.1 Hz), 82.4 (d, J = 7.6 Hz), 65.1, 65.0, 64.9, 60.8, 60.7, 37.7, 37.6, 18.4 
(d, J = 1.9 Hz), 12.3, 12.3, 10.9. 31P-NMR (162 MHz, CDCl3) δ 10.4, 10.0. IR 3668(m), 2972(s), 
2361(m), 2180(w), 1699(w), 1453(m), 1407(s), 1250(s), 1076(s), 882(m). HRMS (ESI) calcd for 
C19H28NSi
+ (M+H) 572.2379, found 572.2570. 
 
Diethyl (phenylethynyl)phosphonate (7j)11 
 
H-phosphite 5a (26 mg, 0.18 mmol) and Ph-EBX (6b) were used in general procedure A. 7j was 
obtained as a colorless gel (30 mg, 0.13 mmol, 69% yield). Rf 0.45 (pentane/EtOAc 1/1, 
KMnO4); pentane/EtOAc 1/1 was used as the eluting solvents for purification. 1H-NMR (400 
MHz, CDCl3) δ 7.60 – 7.52 (m, 2H, Ph CH), 7.50 – 7.32 (m, 3H, Ph CH), 4.37 – 4.13 (m, 4H, Et 
CH2), 1.40 (td, J = 7.1, 0.7 Hz, 6H, Et CH3). 13C-NMR (101 MHz, CDCl3) δ 132.6 (d, J = 2.5 
Hz), 130.7, 128.6, 119.6 (d, J = 5.6 Hz), 99.1 (d, J = 52.9 Hz), 79.8 (d, one peak mixing with 
CDCl3), 63.3 (d, J = 5.5 Hz), 16.2 (d, J = 7.0 Hz). 31P-NMR (162 MHz, CDCl3) δ -6.0. IR 
                                                          
11 Wang, Y.; Gan, J.; Liu, L.; Yuan, H.; Gao, Y.; Liu Y.; Zhao, Y.  J. Org. Chem, 2014, 79, 3678. 
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3674(s), 3344(m), 2973(s), 2361(s), 2180(w), 1452(s), 1374(s), 1251(s), 1051(s), 881(m). The 
characterization data is in accordance with reported literature values.11 
 
Diethyl (3,3-dimethylbut-1-yn-1-yl)phosphonate (7k)   
 
H-phosphite 5a (46 mg, 0.32 mmol) and tBu-EBX (6c) were used in general procedure A. 7k was 
obtained as a colorless gel (58 mg, 0.27 mmol, 80% yield). Rf 0.55 (pentane/EtOAc 1/1, 
KMnO4); pentane/EtOAc 1/1 was used as the eluting solvents for purification. 1H-NMR (400 
MHz, CDCl3) δ 4.17 – 4.02 (m, 4H, Et CH2), 1.33 (td, J = 7.1, 0.8 Hz, 6H, Et CH3), 1.25 (s, 9H, 
tBu). 13C-NMR (101 MHz, CDCl3) δ 110.2 (d, J = 50.8 Hz), 68.7 (d, J = 301.8 Hz), 62.8 (d, J = 
5.5 Hz), 29.8, 27.9, 16.0. 31P-NMR (162 MHz, CDCl3) δ -5.7. IR 3676(s), 2988(s), 2361(s), 
2180(w), 1407(m), 1394(s), 1251(s), 1083(s), 893(m), 798(m). HRMS (ESI) calcd for 
C10H19O3P
+ (M+H) 219.1071, found 219.1150. 
 
Diethyl oct-1-yn-1-ylphosphonate (7l) 
 
H-phosphite 5a (23 mg, 0.16 mmol) and nHex-EBX (6d) were used in general procedure A. 7l 
was obtained as a colorless gel (34.5 mg, 0.14 mmol, 86% yield). Rf 0.3 (pentane/EtOAc 1/2, 
KMnO4); pentane/EtOAc 1/1 was used as the eluting solvents for purification. 1H-NMR (400 
MHz, CDCl3) δ 4.29 – 3.99 (m, 4H, Et CH2), 2.33 (td, J = 7.2, 4.4 Hz, 2H, propargyl CH2), 1.66 
– 1.49 (m, 2H, CH2), 1.47 – 1.15 (m, 12H, CH2 and ethyl CH3), 0.88 (dd, J = 7.5, 6.1 Hz, 3H, 
Me). 13C-NMR (101 MHz, CDCl3) δ 103.2 (d, J = 52.9 Hz), 70.4 (d, J = 303.2 Hz), 62.9 (d, J = 
5.5 Hz), 31.1, 28.4, 27.4 (d, J = 2.2 Hz), 22.4, 19.2 (d, J = 4.5 Hz), 16.1 (d, J = 7.1 Hz), 14.0. 31P-
NMR (162 MHz, CDCl3) δ -6.1. IR 3662(s), 2988(w), 2207(w), 1394(m), 1251(m), 1057(s), 
893(m). HRMS (ESI) calcd for C12H24O3P
+ (M+H) 247.1458, found 247.1470. 
 
Diphenyl((triisopropylsilyl)ethynyl)phosphine oxide (9a) 
 
H-phosphine oxide 8a (48.7 mg, 0.233 mmol) and TIPS-EBX (6a) were used in general 
procedure B. 9a was obtained as a colorless gel (81 mg, 0.21 mmol, 91% yield). Rf 0.5 
(pentane/EtOAc 1/1, KMnO4); pentane/EtOAc 1/1 was used as the eluting solvents for 
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purification. 1H-NMR (400 MHz, CDCl3) δ 7.85 (ddd, J = 13.8, 8.3, 1.5 Hz, 4H, Ph CH), 7.55 – 
7.48 (m, 2H, Ph CH), 7.48 – 7.41 (m, 4H, Ph CH), 1.21 – 1.00 (m, 21H, TIPS). 13C-NMR (101 
MHz, CDCl3) δ 133.2 (d, J = 120.9 Hz), 132.1 (d, J = 2.9 Hz), 130.9 (d, J = 11.2 Hz), 128.5 (d, J 
= 13.5 Hz), 113.4 (d, J = 18.8 Hz), 101.1 (d, J = 151.5 Hz), 18.5, 11.0. 31P-NMR (162 MHz, 
CDCl3) δ 6.9. IR 3674(s), 2991(s), 2361(s), 2121(w), 1934(w), 1407(s), 1251(s), 1081(s), 893(s), 
791(m). HRMS (ESI) calcd for C23H32OPSi
+ [M+H]+ 383.1955, found 383.1957. 
 
Di-p-tolyl((triisopropylsilyl)ethynyl)phosphine oxide (9b) 
 
H-phosphine oxide 8b (53.7 mg, 0.233 mmol) and TIPS-EBX (6a) were used in general 
procedure B. 9b was obtained as a colorless gel (85 mg, 0.21 mmol, 89% yield). Rf 0.45 
(pentane/EtOAc 1/1, KMnO4); pentane/EtOAc 1/1 was used as the eluting solvents for 
purification. 1H-NMR (400 MHz, CDCl3) δ 7.72 (dd, J = 13.6, 8.1 Hz, 4H, Ar CH), 7.24 (dd, J = 
8.1, 3.0 Hz, 4H, Ar CH), 2.36 (s, 6H, Me), 1.22 – 1.01 (m, 21H, TIPS). 13C-NMR (101 MHz, 
CDCl3) δ 142.5 (d, J = 3.0 Hz), 130.8 (d, J = 11.6 Hz), 129.5, 129.2 (d, J = 13.8 Hz), 112.4 (d, J 
= 18.8 Hz), 101.5 (d, J = 150.4 Hz), 21.5, 18.4, 11.0. 31P-NMR (162 MHz, CDCl3) δ 7.2. IR 
3674(s), 3319(w), 3227(w), 2972(s), 2361(s), 2190(w), 1933(w), 1452(m), 1407(s), 1251(s), 
1056(s), 893(s), 803(w). HRMS (ESI) calcd for C25H36OPSi
+ [M+H]+ 411.2268, found 
411.2267. 
 
Bis(4-fluorophenyl)((triisopropylsilyl)ethynyl)phosphine oxide (9c) 
 
 
H-phosphine oxide 8c (45 mg, 0.18 mmol) and TIPS-EBX (9a) were used in general procedure 
B. 9c was obtained as a colorless gel (70 mg, 0.17 mmol, 93% yield). Rf 0.5 (pentane/EtOAc 1/1, 
KMnO4); pentane/EtOAc 1/1 was used as the eluting solvents for purification. 1H-NMR (400 
MHz, CDCl3) δ 7.90 – 7.76 (m, 4H, Ar CH), 7.15 (td, J = 8.7, 2.3 Hz, 4H, Ar CH), 1.20 – 1.03 
(m, 21H, TIPS). 13C-NMR (101 MHz, CDCl3) δ 165.3 (dd, J = 254.0, 3.5 Hz), 133.4 (dd, J = 
12.9, 8.9 Hz), 129.0 (dd, J = 125.1, 3.4 Hz), 116.1 (dd, J = 21.6, 14.8 Hz), 114.3 (d, J = 19.6 Hz), 
100.7 (d, J = 154.4 Hz), 18.48, 10.99. 31P-NMR (162 MHz, CDCl3) δ 4.6. 19F-NMR (376 MHz, 
CDCl3) δ -106.0. IR 3674(s), 3391(m), 3226(m), 2958(s), 2361 (s), 2125(w), 1933(w), 1082(s), 
893(s), 802(w). HRMS (ESI) calcd for C23F2H30OPSi
+ [M+H]+ 419.1766, found 419.1767. 
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Dibutyl((triisopropylsilyl)ethynyl)phosphine oxide (9d) 
 
H-phosphine oxide 8d (39 mg, 0.23 mmol) and TIPS-EBX (6a) were used in general procedure 
B. 9d was obtained as a colorless liquid (69 mg, 0.20 mmol, 86% yield, 95% purity).  Rf 0.5 
(MeOH/CH2Cl2 1/10, KMnO4); MeOH/CH2Cl2 3/100 was used as the eluting solvents for 
purification. 1H-NMR (400 MHz, CDCl3) δ 1.95 – 1.76 (m, 4H, Bu CH2), 1.75 – 1.57 (m, 4H, Bu 
CH2), 1.46 (h, J = 7.3 Hz, 4H, Bu CH2), 1.16 – 1.02 (m, 21H, TIPS), 0.93 (t, J = 7.3 Hz, 6H, Me). 
13C-NMR (101 MHz, CDCl3) δ 109.3 (d, J = 15.6 Hz), 31.2 (d, J = 78.9 Hz), 24.2 (d, J = 3.7 
Hz), 23.9 (d, J = 15.6 Hz), 18.4, 13.6, 10.9.12 31P-NMR (162 MHz, CDCl3) δ 25.3. IR 3675(m), 
3385(m), 2972(sh), 2902(s), 2361(s), 2180(w), 1921(w), 1453(m), 1394(s), 1251(s), 1051(sh), 
881(s), 8020(w). HRMS (ESI) calcd for C19H40OPSi
+ [M+H]+ 343.2581, found 343.2584. 
 
tert-Butyl(phenyl)((triisopropylsilyl)ethynyl)phosphine oxide (9e) 
 
H-phosphine oxide 8e (45 mg, 0.25 mmol) and TIPS-EBX (6a) were used in general procedure 
B. 9e was obtained as a colorless gel (78 mg, 0.22 mmol, 87% yield). Rf 0.45 (pentane/EtOAc 
2/1, KMnO4); pentane/EtOAc 2/1 was used as the eluting solvents for purification. 1H-NMR 
(400 MHz, CDCl3) δ 7.86 (ddd, J = 11.9, 8.3, 1.4 Hz, 2H, Ph CH), 7.56 – 7.50 (m, 1H, Ph CH), 
7.45 (tdd, J = 7.0, 3.1, 1.6 Hz, 2H, Ph CH), 1.27 – 1.04 (m, 30H, TIPS and tBu). 13C-NMR (101 
MHz, CDCl3) δ 132.0, 131.9, 129.4 (d, J = 108.0 Hz), 128.0 (d, J = 12.2 Hz), 111.5 (d, J = 14.1 
Hz), 99.5 (d, J = 132.5 Hz), 33.7 (d, J = 82.4 Hz), 23.7, 18.5, 11.0. 31P-NMR (162 MHz, CDCl3) 
δ 29.8. IR 3674(s), 3390(w), 3226(w), 2988(s), 2361(s), 2195(w), 1933(w), 1452(m), 1394(s), 
1251(s), 1056(s), 880(s). HRMS (ESI) calcd for C21H36OPSi
+ [M+H]+ 363.2268, found 
363.2268. 
 
(2R,5R)-2,5-Diphenyl-1-((triisopropylsilyl)ethynyl)phospholane 1-oxide (9f) 
 
H-phosphine oxide 8f (45 mg, 0.18 mmol) and TIPS-EBX (6a) were used in general procedure B. 
9f was obtained as a colorless gel (68 mg, 0.15 mmol, 89% yield). Rf 0.6 (pentane/EtOAc 1/1, 
                                                          
12 One of ethynyl carbons is not strong enough to be recorded.    
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KMnO4); pentane/EtOAc 2/1 was used as the eluting solvents for purification. [α]D23.0 +2.2 (c = 
0.2, CHCl3). 1H-NMR (400 MHz, CDCl3) δ 7.36 – 7.13 (m, 10H, Ph CH), 3.57 (ddd, J = 24.7, 
12.5, 7.1 Hz, 1H, CHPh), 3.35 (td, J = 12.2, 7.6 Hz, 1H, CHPh), 2.63 – 2.19 (m, 3H, CH2), 2.16 – 
1.99 (m, 1H, CH2), 0.88 (m, 21H, TIPS). 13C-NMR (101 MHz, CDCl3) δ 135.5 (dd, J = 43.1, 5.7 
Hz), 128.8 (d, J = 5.5 Hz), 128.6 (dd, J = 10.5, 2.3 Hz), 127.7 (d, J = 5.4 Hz), 127.0 (dd, J = 21.4, 
2.8 Hz), 112.8 (d, J = 13.5 Hz), 100.0 (d, J = 132.1 Hz), 50.5 (d, J = 33.4 Hz), 49.8 (d, J = 33.4 
Hz), 31.1 (d, J = 9.5 Hz), 27.3 (d, J = 11.3 Hz), 18.3, 10.7. 31P-NMR (162 MHz, CDCl3) δ 36.3. 
IR 3671(m), 2987(s), 2361(m), 2180(w), 1407(s), 1251(s), 1059(s), 893(m). HRMS (ESI) calcd 
for for C27H38OPSi
+ [M+H]+ 437.2424, found 437.2425. 
 
(Phenylethynyl)di-p-tolylphosphine oxide (9i) 
 
H-phosphine oxide 8b (31 mg, 0.13 mmol) and Ph-EBX (6b) were used in general procedure B. 
9i was obtained as a colorless solid (32 mg, 0.10 mmol, 72% yield). Rf 0.5 (pentane/EtOAc 1/1, 
KMnO4); pentane/EtOAc 1/1 was used as the eluted solvents for purification. Mp 78 ⁰C; 1H-
NMR (400 MHz, CDCl3) δ 7.78 (dd, J = 13.7, 8.1 Hz, 4H, Ar CH), 7.62 – 7.56 (m, 2H, Ar CH), 
7.47 – 7.41 (m, 1H, Ar CH), 7.37 (tt, J = 6.7, 1.6 Hz, 2H, Ar CH), 7.29 (dd, J = 8.1, 3.0 Hz, 4H, 
Ar CH), 2.40 (s, 6H, Me). 13C-NMR (101 MHz, CDCl3) δ 142.8 (d, J = 3.0 Hz), 132.5, 132.5, 
131.0 (d, J = 11.7 Hz), 130.5, 129.4 (d, J = 13.9 Hz), 128.6, 120.2 (d, J = 4.1 Hz), 105.0 (d, J = 
29.8 Hz), 83.3 (d, J = 169.0 Hz), 21.7. 31P-NMR (162 MHz, CDCl3) δ 9.2. IR ν 3675(s), 3344(s), 
2973(s), 2891(s), 2361(s), 2180(w), 1407(s), 1251(s), 1072(s), 894(s). HRMS (ESI) calcd for 
C22H20OP
+ [M+H]+ 331.1246, found 331.1245.  
 
3,3-Dimethylbut-1-yn-1-yl)di-p-tolylphosphine oxide (9j) 
 
H-phosphine oxide 8b (47 mg, 0.20 mmol) and tBu-EBX (6c) were used in general procedure B. 
9j was obtained as a colorless gel (55 mg, 0.17 mmol, 87% yield). Rf 0.4 (pentane/EtOAc 1/1, 
KMnO4); pentane/EtOAc 1/1 was used as the eluting solvents for purification. 1H-NMR (400 
MHz, CDCl3) δ 7.68 (dd, J = 13.6, 8.0 Hz, 4H, Ar CH), 7.25 (dd, J = 8.0, 2.8 Hz, 4H, Ar CH), 
2.38 (s, 6H, Ar Me), 1.31 (s, 9H, tBu). 13C-NMR (101 MHz, CDCl3) δ 142.3, 130.8 (d, J = 11.6 
Hz), 130.6 (d, J = 124.1 Hz), 129.2 (d, J = 13.8 Hz), 116.1 (d, J = 28.8 Hz), 73.4 (d, J = 173.7 
Hz), 30.0, 28.4, 21.6. 31P-NMR (162 MHz, CDCl3) δ 7.9. IR 3674(s), 2988(s), 2361(s), 2177(w), 
1933(w), 1452(m), 1407(s), 1252(s), 1230(s), 1066(s), 893(s), 778(w). HRMS (ESI) calcd for 
C20H24OP
+ (M+H) 311.1486, found 311.1565. 
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Oct-1-yn-1-yldi-p-tolylphosphine oxide (9k) 
 
H-phosphine oxide 8b (37.7 mg, 0.163 mmol) and nHex-EBX (6d) were used in general 
procedure B. 9k was obtained as a colorless gel (47 mg, 0.14 mmol, 85% yield). Rf 0.35 
(pentane/EtOAc 1/1, KMnO4); pentane/EtOAc 1/1 was used as the eluting solvents for 
purification. 1H-NMR (400 MHz, CDCl3) δ 7.72 (dd, J = 13.6, 8.1 Hz, 4H, Ar H), 7.33 – 7.21 
(m, 4H, Ar H), 2.50 – 2.35 (m, 8H, 2*CH3C6H4 + CH2), 1.70 – 1.56 (m, 2H, CH2), 1.50 – 1.38 
(m, 2H, CH2), 1.36 – 1.21 (m, 4H, CH2), 0.96 – 0.83 (m, 3H, Me).  13C-NMR (101 MHz, CDCl3) 
δ 142.5 (d, J = 3.0 Hz), 130.9 (d, J = 11.6 Hz), 129.7, 129.2 (d, J = 13.8 Hz), 109.3 (d, J = 30.4 
Hz), 75.2 (d, J = 174.4 Hz), 31.2, 28.5, 27.6 (d, J = 1.8 Hz), 22.5, 21.6, 19.8 (d, J = 3.2 Hz), 14.0. 
31P-NMR (162 MHz, CDCl3) δ 8.1. IR 3662(s), 2988(s), 2193(s), 1394(m), 1407(s), 1252(s), 
1057(s), 893(s), 809(w). HRMS (ESI) calcd for C22H28OP
+ (M+H) 339.1872, found 339.1888 
 
4. Spectra of New Compounds 
.  
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